Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
February 28th, 2025
This study provides a protocol for evaluating the interaction of Mycobacterium tuberculosis with the SLAMF1 microbial sensor. The assays were conducted on human monocyte-derived macrophages using flow cytometry and fluorescence microscopy. The described tools are relevant for studying interactions between pathogens and immunoreceptors.
Overview
This study provides a protocol for evaluating the interaction of Mycobacterium tuberculosis with the SLAMF1 microbial sensor. The assays were conducted on human monocyte-derived macrophages using flow cytometry and fluorescence microscopy.
Key Study Components
Area of Science
- Microbiology
- Immunology
- Cell Biology
Background
- Mycobacterium tuberculosis is a significant human pathogen.
- SLAMF1 is a microbial sensor involved in immune responses.
- Understanding pathogen-receptor interactions is crucial for developing therapeutic strategies.
- Human monocyte-derived macrophages are key immune cells in tuberculosis infection.
Purpose of Study
- To evaluate the interaction between Mycobacterium tuberculosis and SLAMF1.
- To develop a protocol for studying these interactions.
- To enhance understanding of pathogen recognition by the immune system.
Methods Used
- Flow cytometry for quantifying cell interactions.
- Fluorescence microscopy for visualizing pathogen uptake.
- Use of human monocyte-derived macrophages as a model system.
- Assays designed to assess SLAMF1 engagement.
Main Results
- Demonstrated interaction between Mycobacterium tuberculosis and SLAMF1.
- Flow cytometry results indicated significant binding events.
- Fluorescence microscopy provided visual confirmation of interactions.
- Findings contribute to the understanding of immune evasion by pathogens.
Conclusions
- The study presents a valuable protocol for future research.
- Insights gained may inform therapeutic approaches against tuberculosis.
- Further exploration of SLAMF1 could enhance immunological knowledge.
Frequently Asked Questions
Executive Industry Relevance
Directly quantifying the interaction between Mycobacterium tuberculosis and the immune receptor SLAMF1 addresses a critical gap in early-stage target validation for infectious disease research. The described fluorescence-based assays enable mechanistic de-risking by providing robust, quantitative evidence of pathogen-receptor engagement without reliance on transgenic models. This capability supports predictive confidence in immunological target selection and informs portfolio decisions in host-pathogen interface programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of pathogen-immune receptor interactions in human-derived systems.
- Supports functional validation of SLAMF1 as a microbial sensor relevant to tuberculosis.
- Provides mechanistic clarity for prioritizing immune targets in infectious disease pipelines.
Screening & Assay Development
- Establishes reproducible, quantitative assays using flow cytometry and fluorescence microscopy.
- Facilitates standardization of pathogen-receptor binding measurements for downstream screening.
- Prepares validated biological systems for scalable compound or antibody evaluation.
Translational & Preclinical Research
- Aligns in vitro findings with disease-relevant immune mechanisms in tuberculosis.
- Enables continuity from discovery-stage validation to preclinical model selection.
- Supports risk-adjusted advancement of immunomodulatory strategies targeting SLAMF1.
Pipeline & Workflow Integration
These fluorescence assays position within the early discovery to lead identification continuum, providing foundational data for target validation and assay readiness in infectious disease research.
- Discovery Biology: Quantifies direct SLAMF1-pathogen interactions to clarify immune recognition pathways.
- Screening: Delivers standardized, reproducible readouts suitable for comparative analysis across conditions.
- Analytics: Generates quantitative binding data supporting statistical evaluation of immune engagement.
- Translational Research: Bridges in vitro immune receptor validation with preclinical model development for tuberculosis.
- Enterprise Reuse: Provides a broadly applicable platform for studying diverse pathogen-immune receptor interactions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune target selection and reduces mechanistic ambiguity.
- Operational Value: Enables standardized, scalable, and reproducible immune interaction assays.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in infectious disease portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of immunological targets for further development.
Implementation Considerations
- Requires expertise in flow cytometry, fluorescence microscopy, and immune cell handling.
- Demands access to analytical instrumentation and validated antibody reagents.
- Necessitates cross-team standardization of assay protocols and data analysis.
- Adaptable to other pathogen-receptor systems with appropriate reagent development.
- Dependent on quality of primary cell extracts and antigen preparations.
Biopharma FAQs
Chapters in this video
0:00
Introduction
2:11
Monocyte-Derived Macrophage Culture, Stimulation, and Protein Extraction
4:42
Investigating SLAMF1- Mycobacterium tuberculosis Interaction by Flow Cytometry
5:32
Investigating SLAMF1- Mycobacterium tuberculosis Interaction by Fluorescence Microscopy
6:42
Representative Results
